Recent research has shown abnormal lipids in acquired immunodeficiency syndrome (AIDS). In human immunodeficiency virus (HIV) infection hypocholesterolaemia, hypertriglyceridaemia and also low high density lipoprotein (HDL)-cholesterol have all been described. In addition, increased dense low density lipoprotein (LDL) particles and also lipoprotein (a) have been observed in some patients.
The use of the protease inhibitors has been associated with diabetes mellitus and also features of insulin resistance. This article looks at these lipid abnormalities in detail and discusses possible therapeutic options that may be available, in order to address them.
BeginM.E., MankuM.S., HorrobinD.F.Plasma fatty acid levels in patients with acquired immune deficiency syndrome and controls.Prostaglandins, Leukotrienes and Essential Fatty Acids1989; 37: 135–7.
2.
BenhamouY., HilmarsdottirI., Despres-LivageI.Association of lipid accumulation in small intestinal mucosa with decreased serum triglyceride and cholesterol levels in AIDS.Dig Dis Sci1994; 39: 2163–9.
3.
Shor-PosnerG., BasitA., LuY., CabrejosC., ChangJ., FletcherM.Hypocholesterolaemia is associated with immune dysfunction in early human immunodeficiency virus-1 infection.Am J Med1993; 94: 515–19.
4.
FalkenbachA., KlaukeS., AlthoffP.H.Abnormalities in cholesterol metabolism cause peripheral neuropathy and dementia in AIDS: a hypothesis.Med Hypotheses1990; 33: 57–61.
5.
StrittmatterC., LangW., WiestlerO.D., KleihuesP.The changing pattern of human immunodeficiency virus-associated cerebral toxoplasmosis: a study of 46 postmortem cases.Acta Neuropathol1992; 83: 475–81.
6.
DouvasG.S., MayM.H., PearsonJ.R., LamE., MillerL., TsuchidaN.Hypertriglyceridaemic serum, very low density lipoprotein and iron enhance Mycobacterium avium replication in human macrophages.J Infect Dis1994; 170: 1248–55.
7.
MugaR., TorJ., Rey-JolyC., PardoA., LlobetP., FozM.Dyslipidaemia and HIV-1 infection in intravenous drug addicts (English abstract).Med Clin1993; 100: 161–3.
8.
ConstansJ., PellegrinJ.L., PeuchantE.Plasma lipids in HIV infected patients: a prospective study in 95 patients.Eur J Clin Invest1994; 24: 416–20.
9.
GrunfeldC., KotlerD.P., ShigenagaJ.K.Circulating interferon-alpha levels and hypertriglyceridaemia in the acquired immunodeficiency syndrome.Am J Med1991; 90: 154–62.
10.
GrunfeldC., PangM., DoerrlerW., ShigenagaJ.K., JensenP., FeingoldK.R.Lipids, lipoproteins, triglyceride clearance and cytokines in human immunodeficiency virus infection and the acquired immunodeficiency syndrome.J Clin Endocrinol Metab1992; 74: 1045–52.
11.
FeingoldK.R., KraussR.M., PangM., DoerrlerW., JensenP., GrunfeldC.The hypertriglyceridaemia of acquired immunodeficiency syndrome is associated with an increased prevalence of low density lipoprotein subclass pattern B.J Clin Endocrinol Metab1993; 76: 1423–7.
12.
HellersteinM.K., GrunfeldC., WuK., ChristiansenM., KaempferS., KletkeC.Increased de novo hepatic lipogenesis in HIV-infected humans.J Clin Endocrinol Metab1993; 76: 559–65.
13.
McLemoreJ.L., BeeleyP., ThortonK., MorrisoeK.Rapid automated determination of lipid hydroperoxide concentrations and total antioxidant status of samples from patients infected with HIV.Am J Clin Pathol1998; 109: 268–73.
14.
SullivanA.K., NelsonM.R.Marked hyperlipidaemia on ritonavir therapy.AIDS1997; 11: 938–9.
15.
EastoneJ.A., DeckerC.F.New onset diabetes mellitus associated with use of protease inhibitor.Ann Intern Med1997; 127: 948
16.
AssmanG., SchulteH.Relation of high density lipoprotein cholesterol and triglycerides to incidence of atherosclerotic coronary artery disease (the PROCAM experience). Prospective Cardiovascular Munster Study.Am J Cardiol1992; 70: 733–7.
Anonymous. Diabetes, protease-inhibitor link unproved: directorate.Can Med Assoc J1997; 157: 502–3.
21.
BergerA.Protease inhibitors may cause fat abnormalities and heart disease.BMJ1998; 317: 100
22.
LoJ.C., MulliganK., ThaiV.W., AlgrenA., SchambelanM.Buffalo hump in men with HIV infection.Lancet1998; 351: 867–70.
23.
MillerK.D., JonesE.J., YanovskiJ.A., ShankarR., FeuersteinI., FalloonJ.Visceral abdominal-fat accumulation associated with use of indinavir.Lancet1998; 351: 871–5.
24.
CarrA., SamarasK., BurtonS.Syndrome of peripheral lipodystrophy and insulin resistance in patients receiving HIV protease inhibitors.AIDS1998; 12: F51–8.
25.
HerryI., BeranardL., de TruchisP., PerronneC.Hypertrophy of the breasts in a patient treated with indinavir.Clin Infect Dis1997; 25: 937–8.
Anonymous. Lipodystrophy in HIV positive patients treated with protease inhibitors. Current Problems in Pharmacovigilance.Committee Safety Med Rep1998; 24: 12
28.
BallS.G.The chemical pathology of AIDS.Ann Clin Biochem1994; 31: 401–9.
29.
HenryK., MelroeH., HuebeschJ., HermundsonJ., SimpsonJ.Atorvastatin and gemfibrozil for protease inhibitor related lipid abnormalities.Lancet1998; 352: 1031–2.
